Katie Jennings is a senior writer at Forbes covering healthcare, technology and AI and a co-author of the InnovationRX newsletter. She joined Forbes in 2020 and is based in Jersey City. Jennings has covered healthcare's most successful entrepreneurs, including billionaire Epic
InnovationRx: Scientists Show How Bird Flu Spreads Between Mammals
Plus: Kamala Harris will likely focus on abortion rights in her presidential campaign; and, here’s why we don’t have an HIV vaccine yet.
Despite Gilead’s Promising HIV Prevention Drug, A Vaccine Is Still The ‘Holy Grail’
The U.N. has proposed a target of ending AIDS by 2030. But it’s a pipe dream unless scientists are able to crack the code of one of the world’s sneakiest viruses.
InnovationRx: Healthcare Venture Capital Funding Rebound?
Health startups raised $5.7 billion in the first half of 2024, per Rock Health. Plus, Element Biosciences snags a $1 billion valuation for its DNA sequencing platform.
InnovationRx: The FTC Is Going After Pharmacy Middlemen
Plus: The first voice box transplant is a success
InnovationRx: A Fourth Dairy Worker Has Contracted Avian Flu
Plus: Biotech Startup Kanvas Biosciences Has Raised $12.5 Million To Find Bacteria That Help Fight Cancer